Alaunos Therapeutics Inc. (TCRT)
NASDAQ · Healthcare
Alaunos Therapeutics Inc. EPS 2011–2025
Alaunos Therapeutics Inc. annual/quarterly eps history and growth rate from 2016 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Alaunos Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.59, a 11.94% decrease year-over-year.
- Alaunos Therapeutics Inc. annual eps for 2025 was $2.20, a 24.66% decrease from 2024.
- Alaunos Therapeutics Inc. annual eps for 2024 was $2.92, a 86.71% decrease from 2023.
- Alaunos Therapeutics Inc. annual eps for 2023 was $21.97, a 741.76% increase from 2022.
- Alaunos Therapeutics Inc. annual eps for 2022 was $2.61.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Alaunos Therapeutics Inc. EPS — FAQ
Alaunos Therapeutics Inc. (TCRT) eps over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Alaunos Therapeutics Inc.'s eps?
Alaunos Therapeutics Inc. (TCRT) reported eps of $-2.20 for fiscal 2025.
Where can I see TCRT's eps history?
The chart and table above show Alaunos Therapeutics Inc.'s eps by year and by quarter, including the growth rate.